Cargando…

Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population

AIMS: Uncertainty exists over the importance of device-detected short-duration atrial arrhythmias. Continuous atrial diagnostics, through home monitoring (HM) technology (BIOTRONIK, Berlin, Germany), provides a unique opportunity to assess frequency and quantity of atrial fibrillation (AF) episodes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanmugam, Nesan, Boerdlein, Annegret, Proff, Jochen, Ong, Peter, Valencia, Oswaldo, Maier, Sebastian K.G., Bauer, Wolfgang R., Paul, Vince, Sack, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262405/ https://www.ncbi.nlm.nih.gov/pubmed/21933802 http://dx.doi.org/10.1093/europace/eur293

Ejemplares similares

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
por: Braunschweig, Frieder, et al.
Publicado: (2019)

The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics
por: Shanmugam, Nesan
Publicado: (2022)

Successful Identification of and Discrimination Between Atrial and Ventricular Arrhythmia with the Aid of Pacing and Defibrillator Devices
por: Mukherjee, Rahul K., et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Triple atrial sensing during cardiac resynchronization
por: Barold, S. Serge, et al.
Publicado: (2020)

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Predictive Value of Left Atrial Remodeling for Response to Cardiac Resynchronization Therapy
por: Bouwmeester, Sjoerd, et al.
Publicado: (2022)

Cardiac Resynchronization Therapy and Left Atrial Remodeling: A Novel Insight?
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Impact of Estimated Left Atrial Pressure on Cardiac Resynchronization Therapy Outcome
por: Beela, Ahmed S., et al.
Publicado: (2023)

Clinical Implications of Device-Detected Atrial Fibrillation in Cardiac Resynchronization Therapy
por: Yoon, Minjae, et al.
Publicado: (2023)

Tricuspid regurgitation after cardiac resynchronization therapy: evolution and prognostic significance( )
por: Stassen, Jan, et al.
Publicado: (2022)

What does left atrial structural remodeling mean in cardiac resynchronization therapy?
por: Shin, Sung-Hee
Publicado: (2020)

Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
por: Stassen, Jan, et al.
Publicado: (2022)

Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response
por: Sultan, A., et al.
Publicado: (2020)

Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy
por: Sticherling, Christian, et al.
Publicado: (2018)

Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response
por: Hwang, Jin Kyung, et al.
Publicado: (2019)

Simultaneous two-sided endocarditis: cardiac resynchronization leads and left atrial appendage occluder
por: von Roeder, Maximilian, et al.
Publicado: (2020)

Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices
por: Miyazawa, Kazuo, et al.
Publicado: (2021)

Hemodynamic monitoring by intracardiac impedance measured by cardiac resynchronization defibrillators: Evaluation in a controlled clinical setting (BIO.Detect HF II study)
por: Delnoy, Peter-Paul Henri Marie, et al.
Publicado: (2021)

False-positive troponin elevation due to an immunoglobulin-G-cardiac troponin T complex: a case report
por: Akhtar, Zaki, et al.
Publicado: (2020)

Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
por: Nedios, Sotirios, et al.
Publicado: (2020)

Right atrial appendage pacing in cardiac resynchronization therapy – haemodynamic consequences of interatrial conduction delay
por: Dąbrowska-Kugacka, Alicja, et al.
Publicado: (2011)

First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapy
por: Duncker, David, et al.
Publicado: (2016)

An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy
por: Bianchi, Stefano, et al.
Publicado: (2022)

Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
por: Gopinathannair, Rakesh, et al.
Publicado: (2018)

Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation
por: Roukoz, Henri, et al.
Publicado: (2020)

Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial
por: Geller, Johann Christoph, et al.
Publicado: (2019)

Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy
por: Mittal, Suneet, et al.
Publicado: (2017)

A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy
por: Cai, Minsi, et al.
Publicado: (2020)

Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction
por: Cho, In-Jeong, et al.
Publicado: (2020)

Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long‐lasting atrial fibrillation episodes
por: Kugler, Lara, et al.
Publicado: (2022)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Successful hybrid cardiac resynchronization therapy in a patient with failing systemic right ventricle and significant tricuspid regurgitation in transposition of the great arteries after atrial switch procedure according to Mustard
por: Nederend, Marieke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cipolhruma106hn2o69fk18dm4